MedPath

Piroxicam

These highlights do not include all the information needed to use PIROXICAM CAPSULES USP safely and effectively. See full prescribing information for PIROXICAM CAPSULES USP. PIROXICAM Capsules USP, for oral useInitial U.S. Approval: 1982

Approved
Approval ID

99351f77-46b8-4741-9193-1a6d6a7b0b18

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 24, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Piroxicam

PRODUCT DETAILS

NDC Product Code71335-1999
Application NumberANDA208340
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateFebruary 10, 2022
Generic NamePiroxicam

INGREDIENTS (11)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
PIROXICAMActive
Quantity: 20 mg in 1 1
Code: 13T4O6VMAM
Classification: ACTIB
D&C RED NO. 28Inactive
Code: 767IP0Y5NH
Classification: IACT
D&C RED NO. 33Inactive
Code: 9DBA0SBB0L
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Piroxicam - FDA Approval | MedPath